GLUCAJECT Trademark

Trademark Overview

On Friday, November 11, 2005, a trademark application was filed for GLUCAJECT with the United States Patent and Trademark Office. The USPTO has given the GLUCAJECT trademark a serial number of 78752027. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2010. This trademark is owned by Intelliject, LLC. The GLUCAJECT trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, drug delivery systems comprised of auto-injector devices for use in the management of diabetes
glucaject

General Information

Serial Number78752027
Word MarkGLUCAJECT
Filing DateFriday, November 11, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2007

Trademark Statements

Goods and ServicesMedical devices, namely, drug delivery systems comprised of auto-injector devices for use in the management of diabetes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 16, 2005
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINTELLIJECT, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressRICHMOND, VA 23219
Party NameIntelliject, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRichmond, VA 23219
Party NameIntelliject, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRichmond, VA 23219

Trademark Events

Event DateEvent Description
Monday, January 11, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 11, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 7, 2009EXTENSION 4 GRANTED
Thursday, June 11, 2009EXTENSION 4 FILED
Tuesday, July 7, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 11, 2009TEAS EXTENSION RECEIVED
Wednesday, January 14, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 12, 2008EXTENSION 3 GRANTED
Wednesday, November 12, 2008EXTENSION 3 FILED
Wednesday, November 12, 2008TEAS EXTENSION RECEIVED
Thursday, June 12, 2008EXTENSION 2 GRANTED
Thursday, June 12, 2008EXTENSION 2 FILED
Thursday, June 12, 2008TEAS EXTENSION RECEIVED
Monday, December 10, 2007EXTENSION 1 GRANTED
Monday, December 10, 2007EXTENSION 1 FILED
Monday, December 10, 2007TEAS EXTENSION RECEIVED
Thursday, July 12, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 12, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 12, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 28, 2007NOTICE OF PUBLICATION
Wednesday, February 7, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 7, 2007ASSIGNED TO LIE
Friday, January 5, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 15, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 14, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 14, 2006PETITION TO REVIVE-GRANTED
Thursday, December 14, 2006TEAS PETITION TO REVIVE RECEIVED
Thursday, October 19, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 13, 2006WITHDRAWAL OF ATTORNEY GRANTED
Friday, October 13, 2006TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, May 22, 2006NON-FINAL ACTION E-MAILED
Monday, May 22, 2006NON-FINAL ACTION WRITTEN
Wednesday, May 17, 2006ASSIGNED TO EXAMINER
Wednesday, November 16, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

glucaject devices auto injector diabetes comprised management systems namely drug delivery